- Home
- NVOS vs ALBT Comparison
NVOS vs ALBT Comparison
Compare NVOS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVOS
- ALBT
- Stock Information
- Founded
- NVOS 2000
- ALBT 2014
- Country
- NVOS United States
- ALBT United States
- Employees
- NVOS N/A
- ALBT N/A
- Industry
- NVOS Assisted Living Services
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVOS Health Care
- ALBT Health Care
- Exchange
- NVOS Nasdaq
- ALBT Nasdaq
- Market Cap
- NVOS 5.6M
- ALBT 2.9M
- IPO Year
- NVOS 2017
- ALBT N/A
- Fundamental
- Price
- NVOS $0.23
- ALBT $0.20
- Analyst Decision
- NVOS
- ALBT
- Analyst Count
- NVOS 0
- ALBT 0
- Target Price
- NVOS N/A
- ALBT N/A
- AVG Volume (30 Days)
- NVOS 326.8K
- ALBT 639.6K
- Earning Date
- NVOS 12-12-2024
- ALBT 11-12-2024
- Dividend Yield
- NVOS N/A
- ALBT N/A
- EPS Growth
- NVOS N/A
- ALBT N/A
- EPS
- NVOS N/A
- ALBT N/A
- Revenue
- NVOS $13,516,958.00
- ALBT N/A
- Revenue This Year
- NVOS N/A
- ALBT N/A
- Revenue Next Year
- NVOS N/A
- ALBT N/A
- P/E Ratio
- NVOS N/A
- ALBT N/A
- Revenue Growth
- NVOS 1102.98
- ALBT N/A
- 52 Week Low
- NVOS $0.20
- ALBT $0.16
- 52 Week High
- NVOS $3.45
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- NVOS 38.13
- ALBT 42.61
- Support Level
- NVOS $0.20
- ALBT $0.16
- Resistance Level
- NVOS $0.31
- ALBT $0.30
- Average True Range (ATR)
- NVOS 0.03
- ALBT 0.03
- MACD
- NVOS 0.00
- ALBT 0.00
- Stochastic Oscillator
- NVOS 27.18
- ALBT 26.09
About NVOS Novo Integrated Sciences Inc.
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.